Metformin aggravates immune-mediated liver injury in mice.
about
Correlation analysis of peripheral blood T cell subgroups, immunoglobulin and prognosis of early hepatocellular carcinoma after hepatectomy.Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner.Redefining the role of peripheral LPS as a neuroinflammatory agent and evaluating the role of hydrogen sulphide through metformin intervention.Molecular characterization of breast cancer cell response to metabolic drugs.Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response.
P2860
Metformin aggravates immune-mediated liver injury in mice.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Metformin aggravates immune-mediated liver injury in mice.
@en
type
label
Metformin aggravates immune-mediated liver injury in mice.
@en
prefLabel
Metformin aggravates immune-mediated liver injury in mice.
@en
P2093
P2860
P50
P1476
Metformin aggravates immune-mediated liver injury in mice.
@en
P2093
Bojana Simovic Markovic
Dragan Micic
Maja Stojanovic
Marija Milovanovic
Miodrag L Lukic
Vladimir Jakovljevic
Vladimir Trajkovic
P2860
P2888
P304
P356
10.1007/S00204-014-1263-1
P577
2014-04-26T00:00:00Z